시장보고서
상품코드
1426419

세계의 외음부통증 치료 시장 보고서(2024년)

Vulvodynia Treatment Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

외음부통증 치료 시장 규모는 향후 몇 년동안 큰 폭으로 성장할 것으로 예상됩니다. 2028년까지 6.4%의 연평균 복합 성장률(CAGR)로 69억 4,000만 달러 규모에 달할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장은 개인화된 의료 접근법, 정신치료적 개입의 통합, 새로운 치료법에 대한 지속적인 연구, 환자 권한 부여 및 교육에 대한 강조, 세계 건강 이니셔티브의 영향 등의 요인에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 치료 접근법의 발전, 개인 맞춤형 의료 및 표적 치료의 적용, 치료 계획에 심리적 지원의 통합, 새로운 치료 표적에 대한 진행 중인 연구, 외음부 통증의 임상 연구에서의 공동 접근 등이 있습니다.

외음부통증 치료 시장은 비뇨생식기 질환 증가로 인해 성장이 예상되고 있습니다. 생식기 및 비뇨기 계통에 영향을 미치고 당뇨병, 고혈압 등의 증상을 동반하는 비뇨생식기 질환이 증가하고 있습니다. 미국에서만 2022년 약 444,660명이 비뇨생식기암으로 새로 진단받고 약 67,330명이 사망할 것으로 예측됩니다. 난소암을 포함한 이러한 질환의 유병률 증가는 외음부통증 치료 시장의 성장을 가속하는 중요한 요인입니다. 주로 여성의 다양한 비뇨생식기 질환을 대상으로 하는 외음부통증 치료는 통증을 줄이고 증상을 완화하며 환자의 삶의 질을 개선하는 것을 목표로 합니다.

불안증 치료 시장도 여성 불안증 증가로 인해 성장할 것으로 예상됩니다. 긴장, 걱정스러운 생각, 신체적 변화를 특징으로 하는 불안은 여성의 외음부 통증에 대한 높은 감수성과 관련이 있습니다. 불안 수준이 높은 사람은 외음부 통증에 걸릴 확률이 4배 높으며, 외음부 통증의 발병으로 불안과 우울증이 악화되는 경우가 많습니다. 정신 건강 재단의 최근 데이터에 따르면 남성보다 여성의 불안 수준이 눈에 띄게 증가한 것으로 나타났습니다. 여성들의 이러한 불안감 증가는 외음부 통증 치료 시장 성장 촉진요인으로 확인되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 세계 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계 시장 규모 실적과 성장, 2018년-2023년
  • 세계 시장 규모 예측과 성장, 2023년-2028년, 2033년

제6장 시장 세분화

  • 세계의 외음부통증 치료 시장, 약제 유형별 세분화, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 항경련제
  • 삼환계 항우울제
  • 국소 마취제
  • 항균제
  • 호르몬 크림
  • 신경 차단제
  • 기타
  • 세계의 외음부통증 치료 시장, 투여 경로별 세분화, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 경구
  • 외용
  • 기타
  • 세계의 외음부통증 치료 시장, 유통 채널별 세분화, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 병원 약국
  • 온라인 약국
  • 소매 약국

제7장 지역 및 국가별 분석

  • 세계의 외음부통증 치료 시장, 지역별, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 외음부통증 치료 시장, 국가별, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 외음부통증 치료 시장 경쟁 구도
  • 외음부통증 치료 시장 기업 개요
    • Pfizer Inc.
    • Johnson and Johnson Pvt. Ltd.
    • Merck and Co. Inc.
    • AbbVie Inc.
    • Bayer AG

제31장 기타 주요 기업 및 혁신 기업

  • Novartis AG
  • Sanofi SA
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Mylan NV
  • Astellas Pharma Inc.
  • Viatris Inc.
  • Cipla Inc.
  • Hikma Pharmaceuticals plc
  • Endo International Inc.
  • Amneal Pharmaceuticals Inc.

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 가능성 분석

제36장 부록

LSH 24.03.20

Vulvodynia treatment encompasses medical and therapeutic approaches aimed at managing and alleviating the symptoms of vulvodynia-a chronic pain condition characterized by unexplained and persistent discomfort or pain in the vulvar area of the female genitalia. The goal of treatment is to relieve pain, improve a woman's quality of life, and help her resume normal activities, including sexual intercourse.

The main types of drugs used in vulvodynia treatment include anticonvulsants, tricyclic antidepressants, local anesthetics, antimicrobials, hormone creams, and nerve blocks. Anticonvulsants, also known as antiepileptic drugs (AEDs), form a class of pharmaceuticals that normalize the way nerve impulses travel along nerve cells, helping prevent or treat seizures. These drugs can be administered orally, topically, or through other methods and are distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies.

The vulvodynia treatment market research report is one of a series of new reports from The Business Research Company that provides vulvodynia treatment market statistics, including vulvodynia treatment industry global market size, regional shares, competitors with a vulvodynia treatment market share, detailed vulvodynia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the vulvodynia treatment industry. This vulvodynia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vulvodynia treatment market size has grown strongly in recent years. It will grow from $5.04 billion in 2023 to $5.41 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The expansion observed in the historical period can be attributed to factors such as increasing awareness and diagnosis of vulvodynia, changing societal attitudes towards women's health, advances in gynecological understanding and practices, and the presence of patient advocacy and support groups.

The vulvodynia treatment market size is expected to see strong growth in the next few years. It will grow to $6.94 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to factors such as personalized medicine approaches, the integration of psychotherapeutic interventions in vulvodynia treatment, ongoing research on novel therapies, emphasis on patient empowerment and education, and the impact of global health initiatives. Key trends in the forecast period encompass advancements in therapeutic approaches, the application of personalized medicine and targeted therapies, integration of psychological support in treatment plans, ongoing research into novel therapeutic targets, and collaborative approaches in clinical research for vulvodynia.

The vulvodynia treatment market is anticipated to experience growth, driven by the rise in genitourinary diseases. Genitourinary diseases, affecting the reproductive and urinary systems and often associated with conditions such as diabetes or high blood pressure, have been on the increase. In the US alone, it was projected that around 444,660 individuals would receive new diagnoses of genitourinary cancers in 2022, with approximately 67,330 recorded deaths. The escalating prevalence of such diseases, including ovarian cancers, is a significant factor propelling the growth of the vulvodynia treatment market. Vulvodynia treatment primarily targets various genitourinary diseases in females, aiming to alleviate pain, reduce symptoms, and enhance patients' quality of life.

The vulvodynia treatment market is also expected to see growth due to the increasing incidence of anxiety in women. Anxiety, characterized by tension, worried thoughts, and physical changes, is linked to a higher susceptibility to vulvodynia in women. Those with high anxiety levels are four times more prone to vulvodynia, and the development of vulvodynia often exacerbates anxiety and depression. Recent data from the Mental Health Foundation indicates a notable increase in anxiety levels among women compared to men. This surge in anxiety among women is identified as a driving factor for the vulvodynia treatment market.

A significant challenge for the vulvodynia treatment market is the lack of a single treatment approach applicable to all cases. Vulvodynia comprises various subtypes, such as provoked vestibulodynia, generalized vulvodynia, and localized vulvodynia, each potentially requiring a distinct treatment strategy. For example, a pilot study on therapy with local anesthetics revealed varying effectiveness for different patients, indicating the need for personalized treatment plans. The absence of a universally effective treatment for all cases poses a hurdle to the market's growth.

Leading companies in the vulvodynia treatment market are addressing these challenges by developing innovative drugs and obtaining regulatory approvals for treating vulvodynia. Oteseconazole is one such innovative drug developed by Mycovia Pharmaceuticals Inc. This azole antifungal, available in capsule form under the name Vivjoa, received approval from the U.S. Food and Drug Administration (FDA) in July 2022. Vivjoa is prescribed to reduce the risk of recurrent vulvovaginal candidiasis (RVVC) by inhibiting yeast cell growth. The development and approval of such drugs demonstrate a commitment to providing effective and targeted treatments for chronic pain conditions associated with vulvodynia.

In August 2022, Upsher-Smith Laboratories LLC collaborated with Emphascience, Inc., aiming to expand its portfolio with high-touch generic products that address unmet patient needs. Emphascience Inc., specializing in developing novel treatments for chronic pain, entered into this partnership to bring ES-001, a potential solution, to market.

Major companies operating in the vulvodynia treatment market report are Pfizer Inc., Johnson and Johnson Pvt. Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Viatris Inc., Cipla Inc., Hikma Pharmaceuticals plc, Endo International Inc., Amneal Pharmaceuticals Inc., Stada Arzneimittel AG, Glenmark Pharmaceuticals Inc., Alkem Laboratories Limited, Cadila Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Upsher-Smith Laboratories LLC, Noven Pharmaceuticals Inc., National Vulvodynia Association, Zydus Lifesciences Ltd., Depomed Inc.

North America was the largest region in the vulvodynia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vulvodynia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vulvodynia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The vulvodynia treatment market consists of revenues earned by entities by providing services such as pelvic floor physical therapy, cognitive behavioral therapy, acupuncture, exposure therapy, supportive psychotherapy, relaxation therapies, group therapy, stress management, and self-care practices. The market value includes the value of related goods sold by the service provider or included within the service offering. The vulvodynia treatment market also includes sales of topical pain relief products, pregabalin, hydroxyzine, beta-blockers, atypical antipsychotics, and alprazolam. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vulvodynia Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vulvodynia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vulvodynia treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vulvodynia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drug Type: Anticonvulsants; Tricyclic Antidepressants; Local Anesthetics; Antimicrobials; Hormone Creams; Nerve Blocks; Other Drug Types
  • 2) By Route of Administration: Oral; Topical; Other Routes Of Administration
  • 3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson Pvt. Ltd.; Merck and Co. Inc.; AbbVie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vulvodynia Treatment Market Characteristics

3. Vulvodynia Treatment Market Trends And Strategies

4. Vulvodynia Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Vulvodynia Treatment Market Size and Growth

  • 5.1. Global Vulvodynia Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Vulvodynia Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Vulvodynia Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Vulvodynia Treatment Market Segmentation

  • 6.1. Global Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anticonvulsants
  • Tricyclic Antidepressants
  • Local Anesthetics
  • Antimicrobials
  • Hormone Creams
  • Nerve Blocks
  • Other Drug Types
  • 6.2. Global Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Topical
  • Other Routes Of Administration
  • 6.3. Global Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

7. Vulvodynia Treatment Market Regional And Country Analysis

  • 7.1. Global Vulvodynia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Vulvodynia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Vulvodynia Treatment Market

  • 8.1. Asia-Pacific Vulvodynia Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Vulvodynia Treatment Market

  • 9.1. China Vulvodynia Treatment Market Overview
  • 9.2. China Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Vulvodynia Treatment Market

  • 10.1. India Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Vulvodynia Treatment Market

  • 11.1. Japan Vulvodynia Treatment Market Overview
  • 11.2. Japan Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Vulvodynia Treatment Market

  • 12.1. Australia Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Vulvodynia Treatment Market

  • 13.1. Indonesia Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Vulvodynia Treatment Market

  • 14.1. South Korea Vulvodynia Treatment Market Overview
  • 14.2. South Korea Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Vulvodynia Treatment Market

  • 15.1. Western Europe Vulvodynia Treatment Market Overview
  • 15.2. Western Europe Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Vulvodynia Treatment Market

  • 16.1. UK Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Vulvodynia Treatment Market

  • 17.1. Germany Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Vulvodynia Treatment Market

  • 18.5. France Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Vulvodynia Treatment Market

  • 19.9. Italy Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Vulvodynia Treatment Market

  • 20.13. Spain Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Vulvodynia Treatment Market

  • 21.1. Eastern Europe Vulvodynia Treatment Market Overview
  • 21.2. Eastern Europe Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Vulvodynia Treatment Market

  • 22.1. Russia Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Vulvodynia Treatment Market

  • 23.1. North America Vulvodynia Treatment Market Overview
  • 23.2. North America Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Vulvodynia Treatment Market

  • 24.1. USA Vulvodynia Treatment Market Overview
  • 24.2. USA Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Vulvodynia Treatment Market

  • 25.1. Canada Vulvodynia Treatment Market Overview
  • 25.2. Canada Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Vulvodynia Treatment Market

  • 26.1. South America Vulvodynia Treatment Market Overview
  • 26.2. South America Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Vulvodynia Treatment Market

  • 27.1. Brazil Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Vulvodynia Treatment Market

  • 28.1. Middle East Vulvodynia Treatment Market Overview
  • 28.2. Middle East Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Vulvodynia Treatment Market

  • 29.1. Africa Vulvodynia Treatment Market Overview
  • 29.2. Africa Vulvodynia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Vulvodynia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Vulvodynia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Vulvodynia Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Vulvodynia Treatment Market Competitive Landscape
  • 30.2. Vulvodynia Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson Pvt. Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck and Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Vulvodynia Treatment Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Sanofi S.A.
  • 31.3. GlaxoSmithKline plc
  • 31.4. Takeda Pharmaceutical Company Limited
  • 31.5. Eli Lilly and Company
  • 31.6. Amgen Inc.
  • 31.7. Teva Pharmaceutical Industries Ltd.
  • 31.8. Janssen Pharmaceuticals, Inc.
  • 31.9. Mylan N.V.
  • 31.10. Astellas Pharma Inc.
  • 31.11. Viatris Inc.
  • 31.12. Cipla Inc.
  • 31.13. Hikma Pharmaceuticals plc
  • 31.14. Endo International Inc.
  • 31.15. Amneal Pharmaceuticals Inc.

32. Global Vulvodynia Treatment Market Competitive Benchmarking

33. Global Vulvodynia Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Vulvodynia Treatment Market

35. Vulvodynia Treatment Market Future Outlook and Potential Analysis

  • 35.1 Vulvodynia Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Vulvodynia Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Vulvodynia Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제